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in distribution pattern like found in normal lymphoid organs. Additionally, in vitra 
assays showed that the freshly isolated human cells from the scid-hu chimeras were able 
to respond to exogenous stimuli. 
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Xenotransplantation requires down-regulation of natural and graft-induced xenophile 
antibodies (NXA and XA) in the recipient to overcome hyperacute graft rejection. In the 
experimental combination «rat-anti-human» LEW rats received xenoantigen (S x 106 
human PBL i.p. on day 0) in combination with lS-deoxyspergualin (1S-DOS: 2.S mg/kg; 
14 days), very successful in inhibiting kidney and skin allograft rejection, or with 
leflunomide (LF: 3 or 10 mg/kg; 10 days), a weIl tolerated new drug in treating 
experimental autoimmune diseases, or with cyclophosphamide (CY: 120 mg/kg; 6 days), 
known to be particularly effective in down-regulating B lymphocyte activity. Rat 
antibody titers were determined by standard flow cytometry. Results: (1) CY and LF, 
but not lS-DOS, suppress NXA in normal LEW rats (CY> LF). NXA-specific B cell 
clones remain immunologically responsive, as was tested by applying test xenoantigen on 
day +30. (2) In xenogeneically sensitized rats, in which antibody production switches 
from IgM to IgG, CY, LF and lS-DOS inhibit XA production significantly, when 
applied in close correlation to xenoantigen. CY is the most effective in down-regulating 
XA. (3) Repetition of the combined treatment (xenoantigen and drug) on day +30, 
performed with CY or lS-DOS, shows an impressive additional down-regulating effect 
of CY, but not of lS-DOS. This holds not only for XA, but also for NXA, wh ich, as a 
product of presensitization, are known to be very difficult to suppress. Conclusions: The 
present approach, consisting of xenoantigen and individual drugs, appears to be very 
effective in down-regulating the antibody-mediated primary xenograft rejection. Further 
approach es should aim at combining weIl tolerated drugs, such as LF and lS-DOS, with 
a highly effective drug, such as CY in order to establish clinicaIly attractive protocols. 
